Pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Titan Biotech has informed that the Company has received an intimation from Ravinder Gupta, belonging to the Promoter Group, regarding the sale of 1000 equity shares of the Company as per trading plan submitted to stock exchange on 05th August, 2024. The transaction was executed through the open market on September 19, 2025, at a price of Rs 955.08 per equity share. The trading window was not closed at the time of the said transaction. In compliance with the aforesaid regulations, the disclosure in Form C, as received from Ravinder Gupta, is enclosed for reference and records.
The above information is a part of company’s filings submitted to BSE.
